Novo’s semaglutide, the drug within Ozempic and Wegovy, and Lilly’s tirzepatide, the drug within Zepbound and Mounjaro, sit within the vanguard of the escalating course of drugs termed GLP-one agonists. These medication mimic the action of a gut hormone associated with regulating starvation and blood sugar and following originally currently bei… Read More